what if a molecule extracted from a simple mushroom made it possible to treat it?
Research is advancing rapidly to cure cystic fibrosis. After the authorization of Kaftrio at the end of 2022, another molecule derived from an edible mushroom, and very common in the northern hemisphere, could well treat patients who do not yet have a therapeutic solution. Cystic fibrosis is the most common genetic disease with around 6,000 … Read more